US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.56 against a street estimate of 0.26 — a beat of 115.4%.
Analysts rate Embecta Corp a hold (0 buy, 3 hold, 1 sell out of 4) with an average price target of $4.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.12% |
| Yacktman Asset Management Co | 7.62% |
| Vanguard Capital Management, LLC | 4.51% |
| Deerfield Management Co | 4.47% |
| Jefferies Financial Group Inc | 4.16% |
| Ameriprise Financial Inc | 3.60% |
| Morgan Stanley - Brokerage Accounts | 3.52% |
| State Street Corp | 2.84% |
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.01 / share ex-date Aug 27, 2026 · pay Sep 15, 2026 | 2026-08-27 |
| Dividend | $0.01 / share ex-date May 28, 2026 · pay Jun 15, 2026 | 2026-05-28 |
| Dividend | $0.15 / share ex-date Feb 27, 2026 · pay Mar 17, 2026 | 2026-02-27 |
| Dividend | $0.15 / share ex-date Dec 5, 2025 · pay Dec 18, 2025 | 2025-12-05 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Embecta Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.